Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Angi Inc. (ANGI) - free report >>
Zymeworks Inc. (ZYME) - free report >>
Stitch Fix, Inc. (SFIX) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Angi Inc. (ANGI) - free report >>
Zymeworks Inc. (ZYME) - free report >>
Stitch Fix, Inc. (SFIX) - free report >>
Image: Bigstock
New Strong Buy Stocks for July 26th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Angi Inc. (ANGI - Free Report) : This company which connects consumers with home service professionals has seen the Zacks Consensus Estimate for its current year earnings increasing 16.7% over the last 60 days.
Angi Inc. Price and Consensus
Angi Inc. price-consensus-chart | Angi Inc. Quote
Stitch Fix, Inc.(SFIX - Free Report) : This fashion apparel Retailer has seen the Zacks Consensus Estimate for its current year earnings increasing 10.3% over the last 60 days.
Stitch Fix, Inc. Price and Consensus
Stitch Fix, Inc. price-consensus-chart | Stitch Fix, Inc. Quote
Zevia PBC (ZVIA - Free Report) : This beverage company has seen the Zacks Consensus Estimate for its current year earnings increasing 13.5% over the last 60 days.
Zevia PBC Price and Consensus
Zevia PBC price-consensus-chart | Zevia PBC Quote
Zymeworks Inc. (ZYME - Free Report) : This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 16.5% over the last 60 days.
Zymeworks Inc. Price and Consensus
Zymeworks Inc. price-consensus-chart | Zymeworks Inc. Quote
Werewolf Therapeutics, Inc. (HOWL - Free Report) : This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 9.2% over the last 60 days.
Werewolf Therapeutics, Inc. Price and Consensus
Werewolf Therapeutics, Inc. price-consensus-chart | Werewolf Therapeutics, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.